KH Neochem Co., Ltd. (TYO:4189)
Japan · Delayed Price · Currency is JPY 2,773.00
+35.00 (1.28%)
May 26, 2026, 3:30 PM JST
KH Neochem Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 111,870 | 115,098 | 119,758 | 115,217 | 114,880 | 117,110 | |
Revenue Growth (YoY) | -8.00% | -3.89% | 3.94% | 0.29% | -1.90% | 51.44% |
Cost of Revenue | 87,469 | 90,232 | 94,504 | 93,279 | 90,434 | 84,876 |
Gross Profit | 24,401 | 24,866 | 25,254 | 21,938 | 24,446 | 32,234 |
Selling, General & Admin | 12,429 | 12,281 | 11,910 | 11,052 | 11,118 | 11,542 |
Research & Development | 1,337 | 1,337 | 1,147 | 939 | 871 | 1,005 |
Operating Expenses | 13,766 | 13,618 | 13,057 | 11,991 | 11,989 | 12,547 |
Operating Income | 10,635 | 11,248 | 12,197 | 9,947 | 12,457 | 19,687 |
Interest Expense | -206 | -197 | -101 | -81 | -86 | -102 |
Interest & Investment Income | 211 | 209 | 186 | 175 | 289 | 136 |
Earnings From Equity Investments | 197 | 278 | 343 | 263 | 450 | 258 |
Other Non Operating Income (Expenses) | -335 | -387 | -225 | 30 | -16 | 216 |
EBT Excluding Unusual Items | 10,502 | 11,151 | 12,400 | 10,334 | 13,094 | 20,195 |
Gain (Loss) on Sale of Investments | - | - | - | - | -660 | 89 |
Gain (Loss) on Sale of Assets | -389 | -360 | -346 | -610 | -386 | -385 |
Asset Writedown | - | - | - | - | - | -111 |
Other Unusual Items | - | - | -137 | - | -414 | - |
Pretax Income | 10,113 | 10,791 | 11,917 | 9,724 | 11,634 | 19,788 |
Income Tax Expense | 2,579 | 2,839 | 3,447 | 2,795 | 3,382 | 5,924 |
Earnings From Continuing Operations | 7,534 | 7,952 | 8,470 | 6,929 | 8,252 | 13,864 |
Minority Interest in Earnings | -155 | -153 | -110 | -103 | -179 | -173 |
Net Income | 7,379 | 7,799 | 8,360 | 6,826 | 8,073 | 13,691 |
Net Income to Common | 7,379 | 7,799 | 8,360 | 6,826 | 8,073 | 13,691 |
Net Income Growth | -11.78% | -6.71% | 22.47% | -15.45% | -41.03% | 238.38% |
Shares Outstanding (Basic) | 35 | 36 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 35 | 36 | 37 | 37 | 37 | 37 |
Shares Change (YoY) | -4.58% | -3.44% | -0.07% | -0.07% | -0.08% | -0.02% |
EPS (Basic) | 209.10 | 218.14 | 225.79 | 184.23 | 217.74 | 368.95 |
EPS (Diluted) | 209.10 | 218.14 | 225.79 | 184.23 | 217.74 | 368.95 |
EPS Growth | -7.55% | -3.39% | 22.56% | -15.39% | -40.98% | 238.42% |
Free Cash Flow | - | 9,130 | -1,450 | 8,110 | -5,271 | 13,358 |
Free Cash Flow Per Share | - | 255.36 | -39.16 | 218.89 | -142.16 | 359.98 |
Dividend Per Share | 105.000 | 105.000 | 90.000 | 90.000 | 85.000 | 75.000 |
Dividend Growth | 16.67% | 16.67% | - | 5.88% | 13.33% | 25.00% |
Gross Margin | 21.81% | 21.60% | 21.09% | 19.04% | 21.28% | 27.52% |
Operating Margin | 9.51% | 9.77% | 10.18% | 8.63% | 10.84% | 16.81% |
Profit Margin | 6.60% | 6.78% | 6.98% | 5.92% | 7.03% | 11.69% |
Free Cash Flow Margin | - | 7.93% | -1.21% | 7.04% | -4.59% | 11.41% |
EBITDA | 17,308 | 17,581 | 17,170 | 14,598 | 16,750 | 24,190 |
EBITDA Margin | 15.47% | 15.28% | 14.34% | 12.67% | 14.58% | 20.66% |
D&A For EBITDA | 6,673 | 6,333 | 4,973 | 4,651 | 4,293 | 4,503 |
EBIT | 10,635 | 11,248 | 12,197 | 9,947 | 12,457 | 19,687 |
EBIT Margin | 9.51% | 9.77% | 10.18% | 8.63% | 10.84% | 16.81% |
Effective Tax Rate | 25.50% | 26.31% | 28.93% | 28.74% | 29.07% | 29.94% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.